Cite
MLA Citation
S. Ross et al.. “Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial.” Diabetes, obesity & metabolism, vol. 17, no. 7, n.d., pp. 699–702. http://access.bl.uk/ark:/81055/vdc_100025935608.0x000032